The Valley Desk

NCT02091999 · Interventional trial

A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4

Overall registry status Completed

Phase 1

Conditions Metastatic Urothelial Cancer and Other Malignant Solid Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov